Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

SARAUX A, FLIPO R-M, FAGNANI F, MASSOL J, CUKIERMAN G, JOUBERT J-M , HUOT-MARCHAND P, COMBE B